Japanese viral encephalitis

Postgraduate Medical Journal

Volumn 78, Issue 918, 2002, Pages 205-215

  Tiroumourougane, S V ^a   Raghava, P ^a   Srinivasan, S ^a  

^a JAWAHARLAL INSTITUTE OF POSTGRADUATE MEDICAL EDUCATION AND RESEARCH   (India)

Author keywords

[No Author keywords available]

Indexed keywords

ANTICONVULSIVE AGENT; ANTIPYRETIC AGENT; DIAZEPAM; FUROSEMIDE; LIDOCAINE; MANNITOL; MIDAZOLAM; PANCURONIUM; PARACETAMOL; PHENOBARBITAL; PHENYTOIN; SEDATIVE AGENT; THIOPENTAL; VIRUS ANTIBODY; VIRUS ANTIGEN; VIRUS VACCINE;

BRAIN CORTEX; CEREBELLUM; CHILD; CLINICAL FEATURE; CONSERVATIVE TREATMENT; CULEX; EPIDEMIC ENCEPHALITIS; FEVER; HUMAN; INCIDENCE; INTRACRANIAL HYPERTENSION; JAPANESE ENCEPHALITIS VIRUS; NEUROTROPISM; NONHUMAN; PREVALENCE; REVIEW; RISK FACTOR; SEIZURE; SENSORY DYSFUNCTION; SPINAL CORD VENTRAL HORN; SYMPTOM; THALAMUS; TROPICS; VECTOR CONTROL; VIRUS DIAGNOSIS; VIRUS ISOLATION; VIRUS TRANSMISSION;

ADOLESCENT; CHILD; CHILD, PRESCHOOL; DIAGNOSIS, DIFFERENTIAL; DISEASE OUTBREAKS; ENCEPHALITIS VIRUS, JAPANESE; ENCEPHALITIS, JAPANESE; HUMANS; INFANT; INFANT, NEWBORN; INTRACRANIAL PRESSURE; MOSQUITO CONTROL; PROGNOSIS; VIRAL VACCINES;

EID: 0036222156     PISSN: 00325473     EISSN: None     Source Type: Journal    
DOI: 10.1136/pmj.78.918.205     Document Type: Review

References (130)

1. Japanese encephalitis - An important cause of acute childhood encephalopathy in Lucknow, India
2. Factors in the changing epidemiology of JE and west Nile fever
3. Viral encephalitis in Southeast Asia
4. The pathology of Japanese encephalitis
5. An outbreak of JE in the Torres Strait, Australia, 1995
6. Recommendations of the Advisory Committee on Immunization Practices (ACIP)
7. Japanese encephalitis
8. Relationship between number of human Japanese encephalitis cases and summer meteorological conditions in Nagasaki, Japan
9. Subclinical Japanese encephalitis. Infections of Americans with limited residence in Korea
10. Japanese B encephalitis in American soldiers in Korea
11. The virulence to man of Japanese encephalitis virus in Thailand
12. Arboviruses (togaviridae and flavivirdae)
13. Monitoring of vectors of Japanese encephalitis
14. Vector diversity in Japanese encephalitis epidemiology with special reference to West Bengal
15. Japanese encephalitis in India
16. Partial sequence of the Japanese encephalitis virus genome
17. Chemical and antigenic structure of flaviviruses
18. Flaviviruses
19. Epitope mapping of flavivirus glycoproteins
20. Japanese encephalitis virus-vaccinia recombinants produce particulate forms of structural proteins and induce high levels of protection against lethal Japanese encephalitis virus infection
21. Encephalitis epidemica Japonica
22. The pathology of Japanese B encephalitis
23. Etat passe et present de l'encephalite Japonaise an Japon
24. Histopathological examination of central nervous system in protracted cases of encephalitis Japonica
25. A case of protracted (151 days) Japanese B encephalitis
26. Japanese encephalitis
27. Japanese encephalitis virus is transported across the cerebral blood vessels by endocytosis in mouse brain
28. Ultra structure changes of mouse brain neurons infected with Japanese encephalitis virus
29. Electron microscopic observation in mice infected with Japanese encephalitis
30. Kinetics of IgM and IgG response to Japanese encephalitis virus in human serum and cerebrospinal fluid
31. Protection of mice against Japanese encephalitis virus by passive administration with monoclonal antibodies
32. Persistence of virus specific IgM and clinical recovery after Japanese encephalitis
33. Fatal outcome in Japanese encephalitis
34. Antibody-dependent enhancement of yellow fever and Japanese encephalitis neurovirulence
35. Studies of Japanese encephalitis in China
36. Cross reactions among flaviviruses in macrophage migration inhibition assay
37. Broad cross-reactivity with marked fine specificity in the cytotoxic T cell response to flaviviruses
38. In vitro T-cell proliferative response to the flavivirus, West Nile
39. Cell-mediated immunity in mice infected with JE virus. II. Passive transfer of immune spleen T cells for life protection in infected mice
40. T-cell activation and induction of antibodies and memory T cells by immunization with inactivated JE vaccine
41. WHO position paper
42. Japanese encephalitis-virus encephalitis: An overview
43. Vaccinating against Japanese encephalitis
44. Clinical diagnosis of an arthropod borne type virus encephalitis in children in North Arcot District, Madras State, India
45. Acute phase of Japanese B encephalitis
46. Clinical profile of epidemic of Japanese encephalitis
47. The first laboratory proven outbreak of Japanese encephalitis in Goa
48. Clinical aspects and experience in the management of Japanese encephalitis patients
49. Clinical features and prognostic indicators of Japanese encephalitis in children in Lucknow (India)
50. Clinical features of Japanese encephalitis: Prognostic and pathophysiological significance in 50 patients
51. Poliomyelitis like illness due to Japanese encephalitis virus
52. Radiological and neurophysiological changes in Japanese encephalitis
53. EEG in Japanese encephalitis: A clinico-radiological correlation
54. A comparative study of Japanese and Herpes simplex encephalitis
55. Japanese encephalitis
56. Comparison of CT scan and MRI findings in the diagnosis of Japanese encephalitis
57. Single photon emission CT findings in acute Japanese
58. SPECT studies of regional cerebral blood flow in 8 patients with Japanese encephalitis in subacute and chronic stage
59. Isolation of a strain of Japanese encephalitis from the blood of a young patient suffering from cardiovascular collapse
60. Isolation of Japanese encephalitis and West Nile viruses from peripheral blood of encephalitis patients
61. Arboviruses
62. The epidemic of Japanese encephalitis in Tamil Nadu and Pondicherry
63. Isolation of Japanese encephalitis virus in clinical specimens using continuous mosquito cell line
64. Comparative evaluation of bioassay and ELISA for detection of Japanese encephalitis virus in field collected mosquitoes
65. A simplified new method for the identification of arboviruses: Virus detection using enzyme immunoassay on cultured cells
66. A reverse passive hemagglutination test for detection of JE virus antigen in cerebrospinal fluid
67. A rapid method for detection of flavivirus antigens - Staphylococcal co-agglutination test using monoclonal antibodies to Japanese encephalitis virus
68. Detection of Japanese encephalitis cell associated antigen in CSF by indirect immunofluorescence
69. Immunocytochemical study of mononuclear cells in peripheral blood and cerebrospinal fluid of patients with Japanese B encephalitis
70. Detection and differentiation of dengue-1 from Japanese encephalitis virus infection by ABC MAC-ELISA
71. Biotin-labelled antigen sandwich enzyme-linked immunosorbent assay BLA-S-ELISA) for the detection of Japanese encephalitis antibody in human and a variety of animal sera
72. Rapid diagnosis of Japanese encephalitis by using an immunoglobulin M dot enzyme immunoassay
73. ACRIA - Antibody capture immunoassay detection of Japanese encephalitis virus immunoglobulin M and G antibodies in cerebrospinal fluid
74. Detection of flaviviruses by reverse transcriptase-polymerase chain reaction with the universal primer set
75. Detection of Japanese encephalitis virus by reverse transcriptase/polymerase chain reaction
76. Clinical features of Nipah virus encephalitis among pig farmers in Malaysia
77. Inhibitory effect of furanonaphthoquinone derivatives on the replication of Japanese encephalitis virus
78. Passive protection of mice, goats and monkeys against Japanese encephalitis virus with monoclonal antibodies
79. The effect of interferon on Japanese encephalitis virus in vitro
80. Effect of high dose dexamethasone on the outcome of acute encephalitis due to Japanese encephalitis virus
81. Management of pediatric head injury
82. Malignant cerebral edema and intracranial hypertension
83. Relation between cerebral blood and cerebral perfusion pressure
84. Cerebral perfusion in healthy preterm and term newborn infants
85. Cerebral perfusion pressure in central nervous system infections of infancy and childhood
86. Monitoring and management of increased intracranial pressure in Reye syndrome: Results in 29 children
87. Neurologic support
88. Experimental study of relation of fever to cerebral edema
89. Pathophysiology and management of the intracranial vault
90. Restricted fluid intake: Rational management of the neurosurgical patient
91. Management of raised intracranial pressure
92. Measurement, analysis and the management of raised intracranial pressure
93. Adverse effects of prolonged hyperventilation in patients with severe head injury: A randomized clinical trial
94. Effect of dose and dose schedule on the response of intracranial pressure to mannitol
95. Effect on intracranial pressure of furosemide combined with varying doses and administration rates of mannitol
96. Clinical study of mannitol and glycerol on raised intracranial pressure and on their rebound phenomenon
97. Mannitol causes compensatory cerebral vasoconstriction and vasodilation in response to blood viscosity changes
98. Effect of mannitol on intracranial pressure and cerebral blood flow and correlation with pressure auto regulation in severely head-injured patients
99. Aggravation of vasogenic cerebral edema by multiple dose mannitol
100. Critical care of children with acute brain injury
101. Osmotic serum pressure in patients treated with furosemide and hypertonic mannitol solution
102. Brain edema
103. Effect of mannitol and furosemide on blood-brain osmotic gradient and intracranial pressure
104. Furosemide and mannitol in the treatment of acute experimental intracranial hypertension
105. Cerebral blood flow, vasoreactivity and oxygen consumption during barbiturate therapy in severe traumatic brain lesions
106. Failure of prophylactic barbiturate coma in the treatment of severe head injury
107. Prognosis of Japanese encephalitis: A multivariate analysis
108. Neuroinfection. Dr S G Desai Oration
109. Effectiveness of live-attenuated Japanese encephalitis vaccine (SA 14-14-2): A case control study
110. Short term safety of live attenuated Japanese encephalitis vaccine (SA 14-14-2): Results of a randomised controlled with 26239 subjects
111. Arboviral infections - General considerations for prevention, diagnosis and treatment in travelers
112. Side effects with Japanese encephalitis vaccine
113. Acute disseminating encephalomyelitis after treatment with Japanese B encephalitis vaccine (Nakayama-Yoken and Beijing strain)
114. Allergic mucocutaneous reactions to Japanese encephalitis vaccine
115. Neurological complications to vaccination against Japanese encephalitis
116. Adverse reactions to Japanese encephalitis vaccine
117. Japanese encephalitis virus fusion protein with a protein A expressed in Escherichia coli confers protective immunity in mice
118. A 27-aminoacid coding region of JE virus E-protein expressed in E coli as fusion protein with glutathione-S-transferase elicit neutrolizing antibody in mice
119. High-level expression of JE virus E protein by recombinant vaccinia virus and enhancement of its extracellular release by the NS3 gene product
120. Flaviviridae
121. Flaviviruses genome organization, expression and replication
122. Japanese encephalitis in children in northern Thailand
123. Detection of autoantibodies to neural antigen in the CSF of Japanese encephalitis patients and correlation of findings with the outcome
124. Laboratory diagnosis of Japanese encephalitis using monoclonal antibodies and correlation of findings with outcome
125. Detection of Japanese encephalitis virus antigens in the cerebrospinal fluid using monoclonal antibodies
126. Rapid diagnosis of Japanese encephalitis by immunofluorescent examination of cerebrospinal fluid
127. Detection of neutralizing antibodies to Japanese encephalitis virus in the cerebrospinal fluid using rapid microneutraliztion test
128. Mannitol and other diuretics in severe neurotrauma
129. Co-existence of cerebral cysticercosis with Japanese encephalitis: A prognostic modulator
130. Protection against Japanese encephalitis by inactivated vaccines